Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 9 EP applications Marie Suzanne Westberg has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 10, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14167842

Treating dyspnea associated with acute heart failure with H2 relaxin

IPC classification:
A61K 38/22, C07K 14/64, A61P 9/04
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14191582

Treatment of familial Mediterranean Fever with anti IL-1b antibodies

IPC classification:
A61K 39/395, C07K 16/24, A61P 37/00, A61P 19/02
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
The patent has been granted
EP13745552

TREATING INFLAMMATION USING SERELAXIN

IPC classification:
A61K 38/00
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13798486

USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE

IPC classification:
A61K 39/395, C07K 16/24, A61P 29/00, A61P 9/00
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
EXAMINATION IN PROGRESS
EP16162699

ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
EXAMINATION REQUESTED
EP15717969

METHODS OF SELECTIVELY TREATING ASTHMA USING IL-13 ANTAGONISTS

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
EXAMINATION REQUESTED
EP16174665

METHOD OF TREATING CHRONIC HEART FAILURE

IPC classification:
A61P 9/04, C07K 14/64, A61K 38/22
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
Request for examination was made
EP15730858

USE OF SERELAXIN TO REDUCE GDF-15

IPC classification:
A61P 11/00, A61P 9/00, A61K 38/22, A61B 5/00, A61K 38/00
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP16729638

USE OF IL-1 BETA BINDING ANTIBODIES TO TREAT PERIPHERAL ARTERIAL DISEASE

IPC classification:
C07K 16/24
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
Request for examination was made

Please Sign in to use this feature